The Priority Review

The stream · Daily digest

The stream: Friday, October 23, 2026

8 briefs from the Federal Register and FDA, grouped by desk. Each is two sentences from one primary source, linked to it.

Machine-summarized from primary sources; not independently reported. How we use automation

Regulation · 4

  1. AMA and EMA issue joint guidance on Ebola vaccine development

    The EMA's Emergency Task Force and the African Medicines Agency released a joint position paper outlining minimum requirements for clinical trials of Bundibugyo virus vaccines, including guidance on when animal toxicity studies may be waived. The paper also recommends early trials in Africa, a single-dose vaccine preference, and a ring trial design for Phase III studies.

    Source: EMA news release, October 23, 2026

  2. FDA corrects patent extension review periods for six drugs

    The FDA corrects the length of the regulatory review period for ANDEMBRY, ANZUPGO, ANKTIVA, BIZENGRI, BRINSUPRI, and DAYVIGO due to calculation errors. The corrections apply to determinations announced on August 10, August 17, and September 9, 2026; no other changes are made.

    Source: Federal Register notice, October 23, 2026

  3. FDA releases draft chapter on chemical hazard control for human food

    The FDA announced the availability of a new draft chapter, Chapter 12: Control of Chemical Hazards, as part of its multichapter draft guidance on Hazard Analysis and Risk-Based Preventive Controls for Human Food. The guidance is not final and is not yet in effect.

    Source: Federal Register proposed rule, October 23, 2026

  4. FDA proposes action levels for cadmium in food for babies and young children

    The FDA announced a draft guidance titled "Action Levels for Cadmium in Processed Food Intended for Babies and Young Children" that will establish action levels for cadmium in certain processed foods intended for babies and young children less than 2 years old. The draft guidance is intended to set achievable action levels that will help further reduce cadmium in the food supply.

    Source: Federal Register proposed rule, October 23, 2026

Policy · 3

  1. CMS proposes pre-eligibility verification rule for health exchanges

    The rule would require exchanges to verify household income, family size, citizenship status and residence before providing financial assistance, with the first pre-Open-Enrollment verification window beginning August 1, 2027 for 2028 coverage. Stakeholders may submit comments during the 30-day period following publication.

    Source: CMS fact sheet, October 23, 2026

  2. UCB establishes Emmanuel Janssen Endowed Chair at Brigham and Women's Hospital

    UCB announced the creation of a permanently endowed chair in pharmacoepidemiology and pharmacoeconomics at Brigham and Women's Hospital, naming Sebastian Schneeweiss, MD, ScD, as the inaugural incumbent. The chair is intended to advance real-world evidence research and improve how medicines are evaluated and used in clinical practice.

    Source: Company press release (PR Newswire), October 23, 2026

  3. CMS launches $275 million initiative to recruit nurses in nursing homes

    The initiative, funded by CMS and states, is expected to support more than 4,000 nurses and nursing students nationwide, offering up to $40,000 in student loan repayment or a $10,000 stipend for a three-year commitment in rural or higher labor-shortage areas. CMS has committed $100 million, with states committing at least an additional $175 million.

    Source: CMS press release, October 23, 2026

Approvals · 1

  1. FDA approves first once-weekly insulin for type 2 diabetes in pediatric patients

    Awiqli (insulin icodec-abae) is approved for children aged 10 years and older with type 2 diabetes mellitus. The drug is administered by subcutaneous injection once weekly and was approved after a priority review.

    Source: FDA approval notification, October 23, 2026